(IN BRIEF) Dr Amanda Pearce of Loughborough University has received a substantial grant from the Academy of Medical Sciences as part of the Springboard programme, which supports 62 early-career researchers across the UK with awards ranging from £100,000 to £125,000. … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Alzheimer’s disease, blood-brain barrier, career development, CRISPR/Cas9 therapy, dementia, DNA modification, Dr Amanda Pearce, early-career researchers, fluorescent polymer nanoparticles, Healthcare Innovation, leadership, Loughborough University, mentoring, neurodegenerative diseases, NHS burden, research funding, Springboard programme, UK science
(IN BRIEF) Dr Rosie Walker from the University of Exeter’s Psychology department has been honored as an emerging scientific leader under the Academy of Medical Sciences’ largest funding round for early-career researchers, part of a £7.6 million initiative tackling major … Read the full press release
Posted in Awards, Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, addiction, Alzheimer’s disease, Awards, Cancer, climate change impacts, cognitive function, dementia, Dr Rosie Walker, early lecturer, early-career researchers, emerging scientific leader, health challenges, intervention strategies, leadership, mentoring, Obesity, Springboard programme, UK research investment, University of Exeter, £7.6 million funding
(IN BRIEF) Roche presented new data at the AD/PD 2025 International Conference demonstrating that trontinemab, in its Phase Ib/IIa Brainshuttle™ AD study, achieves rapid and dose-dependent reductions of amyloid plaques in the brain, with significant biomarker improvements observed in fluid … Read the full press release
Posted in Austria, Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged AD/PD 2025 International Conference, Alzheimer’s disease, amyloid plaques, ARIA-E, biomarkers, Brainshuttle AD study, cognitive impairment, diagnostic solutions, dose-dependent reduction, Elecsys pTau181 plasma test, Levi Garraway, neurogranin, Phase Ib/IIa study, Phase III programme, pTau181, pTau217, Roche, total tau, trontinemab
(IN BRIEF) Researchers at the University of Liverpool have identified a new mechanism in Alzheimer’s disease involving the interaction between Amyloid Precursor Protein (APP) and talin, a synaptic scaffold protein. This study reveals that disruptions in this mechanical signaling pathway … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Alzheimer’s disease, Professor Ben Goult, University of Liverpool
(IN BRIEF) H.U. Group Holdings Inc. and Fujirebio have announced the launch of Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems. These assays can quantitatively measure Neurofilament light (NfL) … Read the full press release
Posted in Belgium, Education, Healthcare, Management, News, Science, Technology
Tagged Alzheimer’s disease, Belgium, Christiaan De Wilde, CLEIA, Fujirebio, H.U. Group Holdings, human cerebrospinal fluid (CSF), LUMIPULSE G immunoassay systems, Lumipulse G NfL Blood assays, Lumipulse G NfL CSF, multiple sclerosis, Neurofilament light (NfL), Parkinson disease, plasma/serum, Quantitative NfL Assays, Research Use Only
(PRESS RELEASE) HELSINKI, 27-Dec-2021 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland, and University Hospital Helsinki, Finland’s largest provider of healthcare services, have announced a new study that investigates the connection between … Read the full press release
Posted in Education, Finland, Healthcare, News, Science, Technology
Tagged Acta Neuropathologica Communications, Alzheimer, Alzheimer’s disease, APOE4 allele, cerebral microhaemorrhages, FinnGen project, genetic homogeneity, Helsinki University Hospital, Johanna Hästbacka, Liisa Myllykangas, memory disorders, mental fatigue, RESEARCH, study, University of Helsinki, ε4 allele
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?